European Consensus-platform for Alternatives (ECOPA).
A final report of the use of 3R-alternative methods to refine,reduce and replace experimental animals in the development process of product types for human health.
Research
Moving from Animal Models to the Clinic ( pdf | 88 KB )
Cambridge Healthtech Institute, Insight Pharma Reports.
A complimentary market research study on drug development and the use of computer based mathematical models and virtual animal models.
The Wyss Institute.
Microchips lined by human cells that could revolutionize drug testing and development.
National Center for the Replacement, Refinement, & Reduction of Animals in Research (NC3Rs).
This roadmap, vision and strategy for non-animal technologies in the UK has been drawn up by Innovate UK, the National Centre for the Replacement, Refinement and Reduction of Animals in Research, intended to guide the efforts of all those working in this area.
NIH. National Center for Advancing Translational Sciences(NCATS).
National Center for Advancing Translational Sciences (NCATS), along with the Defense Advanced Research Projects Agency and the Food and Drug Administration develop of 3-D engineered tissue platforms, called tissue chips or organs-on-chips that mimic tissues and organ systems